Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
This video discusses intravascular hemolytic anemias, focusing on paroxysmal nocturnal hemoglobinuria (PNH). PNH occurs due to an acquired defect in myeloid stem cells, leading to a lack of…
This informative session covers advances in Paroxysmal Nocturnal Hemoglobinuria (PNH), with discussions on clinical and biological aspects. Experts explore various treatment options, including C5 inhibitors and their efficacy…
Brandi Lewis shares her journey with aplastic anemia and paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder. Initially diagnosed with aplastic anemia in 2008, she went into remission…
Sharon Telesford shares her journey with paroxysmal nocturnal hemoglobinuria (PNH), a rare bone marrow failure disease. Initially misdiagnosed with MDS, Sharon eventually sought specialized care, leading to the…
Robotic surgery represents the latest advancement in minimally invasive surgery, utilizing small incisions for procedures that once required large abdominal or thoracic openings. This technique offers the same…
This video explores the evolving role of biomarkers in kidney cancer treatment, especially as more therapies become available for both metastatic and adjuvant settings. Key questions include which…
Donna, a long-time Huntington Beach resident, shares her journey living with non-small cell lung cancer (NSCLC). Diagnosed with the rare ERBB2 exon 20 mutation, she recounts the initial…
Multiple myeloma is a significant yet lesser-known type of blood cancer. In this Mayo Clinic Health System video, discover key insights about multiple myeloma, including its symptoms, prevalence,…
Stanford Cancer Center is offering new hope to melanoma patients through a groundbreaking cellular therapy called tumor infiltrating lymphocyte (TIL) therapy. This is the first approved cellular therapy…
This video explores the treatment of chronic myeloid leukemia (CML) in special populations. Dr. Mari Copland from the University of Glasgow covers considerations for managing CML in patients…
